mannosamine (cas 2636-92-2) can replace glucosamine in glycosylphosphatidylinositols of Plasmodium falciparum in vitro

Add time:07/12/2019    Source:sciencedirect.com

mannosamine (cas 2636-92-2) (2-deoxy-2-amino-d-mannose) is unable to block GPI biosynthesis in Plasmodium falciparum: neither parasite development nor GPI biosynthesis were blocked by mannosamine treatment in P. falciparum cultures. Further, it was shown by metabolic labeling with [3H]mannosamine and subsequent monosaccharide analysis by high pH anion exchange chromatography that mannosamine is converted at a high rate into glucosamine. Both mannosamine and glucosamine are incorporated into P. falciparum glycolipids, but the characterization of mannosamine-labeled glycolipids synthesized in vivo proved difficult. Therefore, a cell-free system was developed to investigate the incorporation of [3H]mannosamine into glycolipids in P. falciparum. It was observed that mannosamine is incorporated in vitro into P. falciparum glycolipids, which possess a phosphate group. Chemical (nitrous acid deamination, mild acid hydrolysis and alkaline hydrolysis) and enzymatic (PI-PLC) treatments of [3H]mannosamine-labeled glycolipids synthesized in vitro showed the presence of GPIs. Further analyses by Bio-Gel P4 size-exclusion chromatography and HPAEC demonstrated the presence of a mannosamine-containing GPI-like structures, where mannosamine is incorporated instead of glucosamine, i.e. Man3-ManN-PI. This utilization of mannosamine is novel and not been described for any other cellular or parasitic system.

We also recommend Trading Suppliers and Manufacturers of mannosamine (cas 2636-92-2). Pls Click Website Link as below: cas 2636-92-2 suppliers

Prev:Electroanalytical characterization of Zn (II) complexes with D-mannosamine (cas 2636-92-2) and Glycine in aqueous solutions
Next:Effects of long-term exposure to glucosamine and mannosamine (cas 2636-92-2) on aggrecan degradation in articular cartilage)